Medpace Holdings, Inc. — Form 10-Q
Filed July 23, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
Standard SOX 302/906 certifications by August J. Troendle (CEO/Chairman) and Kevin M. Brady (CFO) dated July 23, 2026 for Q2 2026 10-Q. Certifiers attest to accuracy of financial statements, effectiveness of disclosure controls and internal controls over financial reporting, and no undisclosed material weaknesses or management fraud.
Why this rating
Routine Sarbanes-Oxley certification exhibits; boilerplate compliance filing with no operational, financial, or strategic disclosures.
See more from July 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.